CMAJ

Limitations to antiarrhythmic drug use in patients with atrial fibrillation

Background: Of the antiarrhythmic agents currently marketed in Canada, 5 are commonly used to treat atrial fibrillation (AF). The impact of contraindications, warnings and precautions for the use of ...
CMAJ

Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?

Atrial fibrillation (AF) is the most common cardiac arrhythmia seen in clinical practice, and it contributes substantially to both morbidity and medical costs.1 In this issue Humphries and associates ...
Healio

Contraindications exist between ritonavir/nirmatrelvir and some CV medications

Please provide your email address to receive an email when new articles are posted on . There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of ...
Monthly Prescribing Reference

New Contraindications, Warnings Added to Ritonavir Labeling

The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Norvir (ritonavir; AbbVie) 80mg/mL oral solution, 100mg tablets and 100mg soft-gel caps. Norvir, an ...
Monthly Prescribing Reference

FDA Panel Votes on Brinavess for Rapid Conversion of Recent Onset Afib

The Food and Drug Administration (FDA)’s Cardiovascular and Renal Drugs Advisory Committee voted 2 to 11 against the approval of Brinavess (vernakalant hydrochloride; Correvio Pharma) for the rapid ...